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Childhood non-Hodgkin’s lymphomas, including Burkitt and Burkitt-like, are rarely diagnosed in infants. A case of B-
cell lymphoma in a 13-month-old girl with extensive abdominal disease, ascites, pleural effusion, and tumor lysis syndrome
is reported. Phenotypic analysis showed a germinal center B-cell phenotype, and a B-cell clonality was confirmed by
polymerase chain reaction. There was no evidence of Epstein-Barr and HIV infection. The case herein reported emphasizes
the need for considering the diagnosis of lymphoma even in very young children.
DESCRIPTORS: Non-Hodgkin lymphoma. Burkitt lymphoma. Burkitt-like lymphoma. Infant. Childhood cancer.
INTRODUCTION
Non-Hodgkin’s lymphoma (NHL)
is a rare disease in the very young chil-
dren1,2. Small noncleaved cell lym-
phoma (SNCCL) and Burkitt’s and
Burkitt-like lymphomas comprise 40%
- 50% of childhood lymphomas3. The
incidence of SNCCL is age-dependent,
being much higher in the first 2 dec-
ades of life; SNCCL has not been re-
ported in children under 2 years of age.
These lymphomas are B cell in origin
and have the immunophenotypic char-
acteristics of a subset of germinal
center cells. Rare cases of Burkitt and
Burkitt-like lymphoma have been re-
ported in infants2,3. We herein describe
a case of a Burkitt-like SNCCL in a
very young child.
CASE  REPORT
A 13-month-old female infant de-
veloped diarrhea and failure to thrive.
Physical examination revealed a mass
in lower abdominal quadrant and as-
cites. Computed tomography showed
extensive intra-abdominal disease and
right pleural effusion. Laboratory find-
ings showed: red blood count, 3.67 x
1012/L; hemoglobin concentration,
9.5g/dL; haematocrit, 29%; platelet
count, 514 x 10 6/L; white blood cell
count, 10.9 x 106/L with 31%
lymphocytes and 76% neutrophils.
High blood levels of lactic dehydro-
genase (LDH), 2171 IU, and uric acid
(9.2 mg/dL) were consistent with mild
tumor lysis syndrome. An exploratory
laparatomy was performed and re-
vealed diffuse abdominal involvement
including omentum and ovaries, which
were biopsied. The histopathological
analysis showed neoplastic cells simi-
lar in appearance to those of Burkitt’s
lymphoma, but there was increased
pleomorphism over that accepted for
Burkitt’s lymphoma (greater variation
in cell size and shape). The cells
tended to have a more finely dispersed
chromatin pattern and sometimes had
a single prominent eosinophilic nu-
cleolus. Burkitt-like SNCCL was diag-
nosed. Cytogenetic analysis was not
performed in this case.
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Immunohistochemistry showed
strong positivity for CD20 (L26 DAKO).
Pleural effusion phenotypic analysis by
flow cytometry was positive for HLA Dr,
CD19, CD20, IgM, and CD45 and
negative for CD34, CD3, CD4, and
CD8. The cerebrospinal fluid and bone
marrow were negative for the disease.
The St. Jude staging system was ap-
plied, and the patient was classified as
having stage III disease.
B-cell clonality was detected by
PCR using oligonucleotide primers to
amplify rearranged CDRII and CDRIII
regions (semi-nested FR2-JH and FR3-
JH PCRs) of immunoglobulin heavy
chain (IgH) as described elsewhere4,5
(Fig. 1). The HIV test was negative in
the child and her parents. In situ hy-
bridization for Epstein-Barr encoded
RNAs was negative. No evidence of
immunodeficiency was found in this
child. The patient was treated with a
BFM (Berlin-Frankfurt-Münsten)-
based protocol6 and developed mark-
edly elevated serum uric acid levels,
severe electrolyte imbalance, and renal
failure, but recovered with appropriate
treatment. She remains alive, in com-
plete remission for 30 months.
DISCUSSION
Burkitt’s lymphoma (BL) is a B-
cell neoplasm classified in the National
Cancer Institute Working Formulation
as small, noncleaved cell lymphoma7.
In Equatorial Africa, BL is the most
common childhood malignancy, ac-
counting for approximately 80% of
childhood cancers and is called “en-
demic” (eBL). In contrast, outside
Equatorial Africa, BL occurs in a spo-
radic form (sBL). Epstein-Barr (EBV)
viral DNA is found in virtually all
cases of eBL, but in only 15% - 30%
of sBL from the United States 8. In
South America, high association of
EBV with BL was reported in the
Northeast area of Brazil and these EBV
associated BL were observed in young
children9. Both eBL and sBL are char-
acterized by specific chromosomal
translocations that juxtapose areas
within or near the c-myc proto-
oncogene locus on chromosome 8 to
an Ig gene locus on chromosome 2, 14,
or 22. The resulting deregulation of
the c-myc gene has been implicated in
the pathogenesis of the disease10. Pre-
vious studies have shown that the
cases classified as Burkitt-like lacked
c-myc rearrangement and had different
molecular pathogenesis than BL11,12.
Unfortunately, in this case, the molecu-
lar distinction between the two cat-
egories was not performed, and the di-
agnosis was made according to the
morphologic criteria defined by the
REAL classification 13.
This patient presented a B-cell lym-
phoma at an unusually young age at
diagnosis. The histological examina-
tion revealed a Burkitt-like SNCCL.
Non-Hodgkin’s lymphoma (NHL) in-
cluding Burkitt and Burkitt-like, are
rarely described in infants. In 338 con-
secutive newly diagnosed children
with NHL, Murphy et al., found that
4.8% of them were younger than 3
years of age1. Evans et al., reported 6
children who developed NHL before
the age of 3 years associated with
mother-to-child HIV transmission14. In
another report of NHL in children with
vertical HIV infection, 21.7% were un-
der 2 years old15. We have identified 1
infant patient with a Burkitt-like
SNCCL whose HIV test was negative
in the child and her mother, and the
EBV genome was not detected by in
situ hybridization, despite the previ-
ously described relationship between
young age and HIV infection and these
lymphomas10,11.
Prior to the last two decades, child-
hood Burkitt’s NHL was a fatal disease
in most of the cases. In 1976, Wollner
et al. reported the excellent results on
the treatment of childhood NHL using
a novel multiagent chemotherapeutic
regimen, LSA2L216. Several reports in
the past 10 years have shown that
event-free survival has significantly
improved6,17-19. Patients with limited
disease currently have an excellent
prognosis (90% - 100%)6,17. The prob-
ability of cure is obviously influenced
by many factors, among which the
most important are the total body bur-
den of tumor and intensity of chemo-
therapy6. The former is reflected
Figure 1 - Clonal IgH (CDRIII) gene rearrangement detected by FR3-JH polymerase chain
reaction (PCR). Lane 1: 100 bp ladder (GIBCO-BRL) size marker; lane 2: biallelic rearrangement
in pleural liquid, lane 3: positive control (Cemo-1 cell line); lane 4: rearrangement in abdominal
tumor, identical pattern as pleural liquid; lane 5: PCR amplification without DNA template.
Negative image of an 8% polyacrylamide gel with silver staining.
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mainly by the stage of disease and
LDH serum level at diagnosis20. In the
past, the prognosis for patients with
high tumor burdens or with central
nervous system involvement was very
poor21. This situation has changed
markedly in recent years, and patients
with stage III Burkitt and Burkitt-like
SNCCL including those with exten-
sive intra-abdominal disease, have a
60% - 80% long-term survival rate6,18.
Tumor lysis syndrome is often present
at diagnosis or after initiation of treat-
ment. This emergent clinical situation
should be anticipated prior to starting
treatment. Despite the high tumor bur-
den found, our patient achieved long-
term complete remission, probably re-
lated to the intensive therapy.
The current report illustrates the
importance of considering NHL in the
differential diagnosis of neoplasia in
very young children, even when HIV
is not present.
RESUMO
KLUMB CE e col. - Linfoma burkitt-
like em um lactente: relato de caso.
Rev. Hosp. Clín. Fac. Med. S.
Paulo 58(1):33-36, 2003.
Os linfomas não Hodgkin da infân-
cia, incluindo os linfomas de Burkitt
e Burkitt-like são raros em lactentes.
Um caso de linfoma não Hodgkin B em
uma lactente de 13 meses de idade é
descrito. Ao diagnóstico a paciente
apresentava extenso comprometimen-
to abdominal associado à ascite, der-
rame pleural e síndrome de lise
tumoral. A análise imunofenotípica
mostrou um fenótipo compatível com
células linfóides oriundas do centro
germinativo e a origem clonal dessas
células foi demonstrada por reação em
cadeia da polimerase. Não foi demons-
trada associação do linfoma com infec-
ção pelo vírus Epstein-Barr e/ou virus
da imunodeficiência adquirida. O caso
apresentado enfatiza a necessidade de
considerar o diagnóstico de linfoma
mesmo em lactentes.
DESCRITORES: Linfoma não-
Hodgkin. Linfoma de Burkitt. Linfo-
ma Burkitt-like. Lactente. Neoplasias
na infância.
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